MedPath

DWI MR imaging for dedicated staging of patients with peritoneal seeding.

Not yet recruiting
Conditions
peritoneal carcinomatosis
10027476
Registration Number
NL-OMON43419
Lead Sponsor
The Netherlands Cancer Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- Patients already scheduled for cytoreductive surgery +/- HIPEC procedure with histology proven colorectal or ovarian cancer
- Age >18 years
- Written informed consent

Exclusion Criteria

- contraindication for MRI (metal) or MRI contrast agent (Gadolinium)
- contraindicaties for Buscopan
- allergie voor ananassap
- age < 18 years
- pregnant women

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- Prediction of PCI with DWI MRI, using the surgically determined PCI as the<br /><br>reference standard.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- MR Scan quality; good / moderate / poor<br /><br>- Comparison of the diagnostic performance of DWI-MRI in assessing the PCI with<br /><br>the results of CT (=common practice) in colorectal cancer patients.</p><br>
© Copyright 2025. All Rights Reserved by MedPath